BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has entered into a supply agreement with ...
Tampa, FL, July 19, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc. (UATG) (“UAT Group”) announced today that its subsidiary Ossifix Orthopedics has added a new product to its ...
Please provide your email address to receive an email when new articles are posted on . ACL reconstruction with bone marrow aspirate, demineralized bone matrix and suture tape may improve functional ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that ...
LOS ANGELES, Jan. 13, 2026 /PRNewswire/ -- Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, announced today that a sixth patent (U.S. Patent ...
The schematic illustration of the synthesis process of Qx-D (A) and the rat model of femoral infectious bone defect (B). In the realm of orthopedic medicine, the challenge of managing infected bone ...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove ™, ...
BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress with advancing its product candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results